Daniel Arumí

Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: A decision-tree model

Salvador Arlandis, Carlos Errando Smet, Jeffrey Trocio et al. · BMC Urology · 2011 · 33 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

A pooled analysis of the efficacy of fesoterodine for the treatment of overactive bladder, and the relationship between safety, co-morbidity and polypharmacy in patients aged 65 years or older

Adrian Wagg, Daniel Arumí, Sender Herschorn et al. · Age and Ageing · 2016 · 33 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Quality of Life in Patients with Overactive Bladder

Salvador Arlandis, Miguel A. Ruíz, Carlos Errando et al. · Clinical Drug Investigation · 2012 · 30 citations

Medicine, Internal Medicine, Urology +11

Quality of Life in Patients with Overactive Bladder

Salvador Arlandis, Miguel A. Ruíz, Carlos Errando et al. · Clinical Drug Investigation · 2012 · 27 citations

Medicine, Internal Medicine, Urology +11

Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine <scp>ER</scp>

Steven A. Kaplan, L. Cardozo, Sender Herschorn et al. · International Journal of Clinical Practice · 2014 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16